Articles de revue sur le cancer de l'estomac - Derni ères parutions

InTextoResearch, agence d'information scientifique


InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur le cancer de l'estomac (20 mai 2008):

Hereditary diffuse gastric cancer and lost cell polarity: a short path
to cancer.
Humar B, Guilford P.
Future Oncol. 2008 Apr;4(2):229-39.

Capecitabine in the treatment of advanced gastric cancer.
Lee JL, Kang YK.
Future Oncol. 2008 Apr;4(2):179-98.

Epstein-Barr virus-associated lymphoepithelioma-like gastric
carcinoma.
Herath CH, Chetty R.
Arch Pathol Lab Med. 2008 Apr;132(4):706-9.

The alpha and beta classes carbonic anhydrases from Helicobacter
pylori as novel drug targets.
Nishimori I, Onishi S, Takeuchi H, Supuran CT.
Curr Pharm Des. 2008;14(7):622-30.

Emerging drugs in the treatment of advanced gastric cancer.
Tetzlaff ED, Cen P, Ajani JA.
Expert Opin Emerg Drugs. 2008 Mar;13(1):135-44.

Application of immunohistochemistry to liver and gastrointestinal
neoplasms: liver, stomach, colon, and pancreas.
Geller SA, Dhall D, Alsabeh R.
Arch Pathol Lab Med. 2008 Mar;132(3):490-9.

The role of postoperative adjuvant chemotherapy following curative
resection for gastric cancer: a meta-analysis.
Zhao SL, Fang JY.
Cancer Invest. 2008 Apr-May;26(3):317-25.

Relationship between Helicobacter pylori gastritis, gastric cancer and
gastric acid secretion.
Axon AT.
Adv Med Sci. 2007;52:55-60.

More controversy than ever - challenges and promises towards
personalized treatment of gastric cancer.
Liakakos T, Roukos DH.
Ann Surg Oncol. 2008 Apr;15(4):956-60.

Field defects in progression to gastrointestinal tract cancers.
Bernstein C, Bernstein H, Payne CM, Dvorak K, Garewal H.
Cancer Lett. 2008 Feb 18;260(1-2):1-10.

Genetic detection of free cancer cells in the peritoneal cavity of the
patient with gastric cancer: present status and future perspectives.
Fujiwara Y, Doki Y, Taniguchi H, Sohma I, Takiguchi S, Miyata H,
Yamasaki M, Monden M.
Gastric Cancer. 2007;10(4):197-204.

Innovative genomic-based model for personalized treatment of gastric
cancer: integrating current standards and new technologies.
Roukos DH.
Expert Rev Mol Diagn. 2008 Jan;8(1):29-39.

The multidisciplinary management of gastrointestinal cancer.
Multimodal treatment of gastric cancer.
Moehler M, Galle PR, Gockel I, Junginger T, Schmidberger H.
Best Pract Res Clin Gastroenterol. 2007;21(6):965-81.

The multidisciplinary management of gastrointestinal cancer.
Epidemiology of oesophagogastric cancer.
Lambert R, Hainaut P.
Best Pract Res Clin Gastroenterol. 2007;21(6):921-45.

The potential role of pemetrexed in gastrointestinal cancer.
Meriggi F, Di Biasi B, Caliolo C, Zaniboni A.
Chemotherapy. 2008;54(1):1-8.

Pharmacotherapy for oesophagogastric cancer.
Jackson C, Starling N, Chua YJ, Cunningham D.
Drugs. 2007;67(17):2539-56.

E-cadherin and hereditary diffuse gastric cancer.
Pedrazzani C, Corso G, Marrelli D, Roviello F.
Surgery. 2007 Nov;142(5):645-57.

The E-cadherin gene polymorphism 160C->A and cancer risk: A HuGE
review and meta-analysis of 26 case-control studies.
Wang GY, Lu CQ, Zhang RM, Hu XH, Luo ZW.
Am J Epidemiol. 2008 Jan 1;167(1):7-14.



(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)